Skip to main content
Publish date:

Beckman Hires Watson CFO

Effective Oct. 20, Charles Slacik will leave Watson.

Watson Pharmaceuticals


said Tuesday that its chief financial officer has resigned to join another company.

Effective Oct. 20, Charles Slacik will leave Watson to become CFO at medical-supplies company

TheStreet Recommends

Beckman Coulter


. In the interim, the CFO slot at Watson will be filled by corporate controller and principal accounting officer R. Todd Joyce.

"We appreciate Charlie's contribution to the company's growth over the past three years and wish him the best of luck in his new position," said Allen Chao, Watson's chairman and CEO, in a prepared statement.

Watson's shares closed 11 cents lower Monday at $26.75. Beckman's shares rose $1.08 to $58.40.